BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2010
View Archived Issues
GlaxoSmithKline presents new calcium receptor antagonists
Read More
Pfizer describes novel AMPA receptor agonists
Read More
Humoral responses to DC-Melvac cancer vaccine seen in melanoma patients
Read More
Hepatitis C treatment SCY-635 associated with a high barrier to resistance
Read More
INT-747 promising as add-on therapy to ursodeoxycholic acid for primary biliary cirrhosis
Read More
Updated phase I data disclosed on IMO-2125 in HCV infection
Read More
EMD-1214063 displays potent and selective c-Met inhibition
Read More
Telik presents novel Aurora A/B and VEGFR-2 inhibitors
Read More
Dual TLR7 and TLR9 antagonist has therapeutic effects in mouse model of atherosclerosis
Read More
New FAAH inhibitors claimed by Renovis
Read More
Novartis reports R&D highlights for first quarter of 2010
Read More
Temozolomide shows activity in pituitary tumors and carcinomas
Read More
Oncolytics Biotech completes phase I enrollment for phase I/II Reolysin trial
Read More
FDA recommends reformulation of UCB's Neupro
Read More
Nycomed and Merck & Co. collaborate on commercialization of roflumilast in Canada and Europe
Read More
EMA's CHMP recommends extending indication of tocilizumab
Read More
ALK to acquire Fornix Biosciences' allergy division in The Netherlands
Read More
Penwest provides update on focused business plan
Read More
CHMP recommends Seroquel XR as add-on treatment for major depressive disorder
Read More
New FDA initiative to reduce risks related to infusion pumps
Read More
Presidio and Numerate end HCV research collaboration
Read More
Michael J. Fox Foundation awards grants to advance Parkinson's disease research
Read More
Stem Cell Therapeutics completes 90-day endpoint period for REGENESIS trial
Read More
ACT completes studies to support phase I stem cell trial in SMD
Read More
AD-02 Alzheimer's vaccine progresses to phase II
Read More
CHMP recommends conditional marketing approval for Votrient
Read More
Proteo completes patient recruitment in phase II Elafin trial
Read More